Mary E Morris, MD, PHD | |
55 Fruit St, Massachusetts General Hospital, Boston, MA 02114-2621 | |
(617) 726-8868 | |
Not Available |
Full Name | Mary E Morris |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 23 Years |
Location | 55 Fruit St, Boston, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528026143 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207VE0102X | Obstetrics & Gynecology - Reproductive Endocrinology | 227590 (Massachusetts) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Massachusetts General Physicians Organization Inc | 2466365820 | 3085 |
News Archive
A novel therapy recently approved by the U.S. Food and Drug Administration for patients with Alzheimer's disease amid considerable controversy should not be prescribed by physicians off-label for cerebral amyloid angiopathy (CAA), a similar cerebrovascular condition, according to Steven Greenberg, MD, PhD, director of the Hemorrhagic Stroke Research Program at Massachusetts General Hospital (MGH) and president of the International Cerebral Amyloid Angiopathy Association (ICAAA).
An estimated 9 million Americans eligible for free or reduced premium health insurance under the Affordable Care Act have a second chance to sign up for 2021 coverage, since the Biden administration reopened enrollment on healthcare.gov and states that run their own marketplaces followed suit.
At birth, your body was 100-percent human in terms of cells. At death, about 10-percent of the cells in your body will be human and the remaining 90-percent will be microorganisms. That makes you a "supraorganism," and it is the interactions between your human and microbial cells that go a long way towards determining your health and physical well-being, especially your resistance to infectious diseases.
In women with breast lesions that are suspicious for cancer, based on clinical examination or mammography, performing a breast MRI has high sensitivity but only moderate specificity for detecting breast cancer, but does not necessarily eliminate the need for tissue sampling, according to a study in the December 8 issue of JAMA.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that patient enrollment was recently completed for the company's Phase 2a trial of XOMA 052 in patients with Type 2 diabetes.
› Verified 2 days ago
Entity Name | Massachusetts General Physicians Organization Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
A novel therapy recently approved by the U.S. Food and Drug Administration for patients with Alzheimer's disease amid considerable controversy should not be prescribed by physicians off-label for cerebral amyloid angiopathy (CAA), a similar cerebrovascular condition, according to Steven Greenberg, MD, PhD, director of the Hemorrhagic Stroke Research Program at Massachusetts General Hospital (MGH) and president of the International Cerebral Amyloid Angiopathy Association (ICAAA).
An estimated 9 million Americans eligible for free or reduced premium health insurance under the Affordable Care Act have a second chance to sign up for 2021 coverage, since the Biden administration reopened enrollment on healthcare.gov and states that run their own marketplaces followed suit.
At birth, your body was 100-percent human in terms of cells. At death, about 10-percent of the cells in your body will be human and the remaining 90-percent will be microorganisms. That makes you a "supraorganism," and it is the interactions between your human and microbial cells that go a long way towards determining your health and physical well-being, especially your resistance to infectious diseases.
In women with breast lesions that are suspicious for cancer, based on clinical examination or mammography, performing a breast MRI has high sensitivity but only moderate specificity for detecting breast cancer, but does not necessarily eliminate the need for tissue sampling, according to a study in the December 8 issue of JAMA.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that patient enrollment was recently completed for the company's Phase 2a trial of XOMA 052 in patients with Type 2 diabetes.
› Verified 2 days ago
Entity Name | The General Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
A novel therapy recently approved by the U.S. Food and Drug Administration for patients with Alzheimer's disease amid considerable controversy should not be prescribed by physicians off-label for cerebral amyloid angiopathy (CAA), a similar cerebrovascular condition, according to Steven Greenberg, MD, PhD, director of the Hemorrhagic Stroke Research Program at Massachusetts General Hospital (MGH) and president of the International Cerebral Amyloid Angiopathy Association (ICAAA).
An estimated 9 million Americans eligible for free or reduced premium health insurance under the Affordable Care Act have a second chance to sign up for 2021 coverage, since the Biden administration reopened enrollment on healthcare.gov and states that run their own marketplaces followed suit.
At birth, your body was 100-percent human in terms of cells. At death, about 10-percent of the cells in your body will be human and the remaining 90-percent will be microorganisms. That makes you a "supraorganism," and it is the interactions between your human and microbial cells that go a long way towards determining your health and physical well-being, especially your resistance to infectious diseases.
In women with breast lesions that are suspicious for cancer, based on clinical examination or mammography, performing a breast MRI has high sensitivity but only moderate specificity for detecting breast cancer, but does not necessarily eliminate the need for tissue sampling, according to a study in the December 8 issue of JAMA.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that patient enrollment was recently completed for the company's Phase 2a trial of XOMA 052 in patients with Type 2 diabetes.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Mary E Morris, MD, PHD 55 Fruit St, Massachusetts General Hospital, Boston, MA 02114-2621 Ph: (617) 726-8868 | Mary E Morris, MD, PHD 55 Fruit St, Massachusetts General Hospital, Boston, MA 02114-2621 Ph: (617) 726-8868 |
News Archive
A novel therapy recently approved by the U.S. Food and Drug Administration for patients with Alzheimer's disease amid considerable controversy should not be prescribed by physicians off-label for cerebral amyloid angiopathy (CAA), a similar cerebrovascular condition, according to Steven Greenberg, MD, PhD, director of the Hemorrhagic Stroke Research Program at Massachusetts General Hospital (MGH) and president of the International Cerebral Amyloid Angiopathy Association (ICAAA).
An estimated 9 million Americans eligible for free or reduced premium health insurance under the Affordable Care Act have a second chance to sign up for 2021 coverage, since the Biden administration reopened enrollment on healthcare.gov and states that run their own marketplaces followed suit.
At birth, your body was 100-percent human in terms of cells. At death, about 10-percent of the cells in your body will be human and the remaining 90-percent will be microorganisms. That makes you a "supraorganism," and it is the interactions between your human and microbial cells that go a long way towards determining your health and physical well-being, especially your resistance to infectious diseases.
In women with breast lesions that are suspicious for cancer, based on clinical examination or mammography, performing a breast MRI has high sensitivity but only moderate specificity for detecting breast cancer, but does not necessarily eliminate the need for tissue sampling, according to a study in the December 8 issue of JAMA.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that patient enrollment was recently completed for the company's Phase 2a trial of XOMA 052 in patients with Type 2 diabetes.
› Verified 2 days ago
Sheela S Maru, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 850 Harrison Ave, Yacc 4, Boston, MA 02118 Phone: 617-414-2000 Fax: 617-414-5798 | |
Dr. Devon Abt Harris, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 330 Brookline Ave # Shapiro8, Boston, MA 02215 Phone: 617-667-3736 Fax: 617-667-7493 | |
Maureen E Paul, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 1055 Commonwealth Ave, Boston, MA 02215 Phone: 917-208-9521 | |
Charles-chidi W Obasiolu, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Ctr For Fertility & Repro Hlth, 133 Brookline Ave, Boston, MA 02215 Phone: 617-421-2987 Fax: 617-421-2989 | |
Dr. Erik M Clinton, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 750 Washington St, Boston, MA 02111 Phone: 617-636-5000 | |
Evelyn Hall, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 800 Washington St, Boston, MA 02111 Phone: 269-552-8685 | |
Toni Beth Walzer, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 333 Longwood Avenue, Adolescent Gynecology, Boston, MA 02115 Phone: 617-355-5785 |